Mast cells stimulated with antigen undergo extensive changes in their cytoskeleton. In the present study, we assess the impact of actin-modifying drugs and report that, in the presence of cytochalasin D, mast cells stop membrane ruffling, but instead bleb. Bleb formation is reversible following washout of cytochalasin D and occurs in an actin-polymerizationdependent manner. Bleb formation is inhibited by expression of constitutively active ezrin-T567D. Blebbing is also inhibited by blebbistatin, a myosin II inhibitor, implying myosin II activation in the process. We used a selection of inhibitors and observed that myosin II activation is dependent mainly on Ca 2+ -calmodulin, with only a small contribution from Rho kinase. The signalling pathways stimulated by antigen include PLC (phospholipase C) and PLD (phospholipase D). Bleb formation was dependent on activation of PLC, but not PLD. Primary alcohols, used previously as a means to reduce PLD-derived phosphatidic acid, were potent inhibitors of membrane blebbing, but a more selective inhibitor of PLD, FIPI (5-fluoro-2-indolyl des-chlorohalopemide), was without effect. FIPI also did not inhibit membrane ruffling or degranulation of mast cells, indicating that inhibition by primary alcohols works through an unidentified mechanism rather than via diversion of PLD activity as assumed. We also examined the requirement for ARF6 (ADP-ribosylation factor 6) and observed that its expression led to an increase in bleb size and a further increase was observed with the dominant-active mutant, ARF6-Q67L. Since ARF6-T27N had no effect on bleb size, we conclude that ARF6 needs to be active to regulate the size of the blebs.
INTRODUCTION
Mast cells are multifunctional effector cells of primary importance in innate and adaptive immune responses. They participate in allergic inflammation, host defence, immunological tolerance and autoimmune disease, atherosclerosis and cancer [1] [2] [3] [4] [5] . In addition to their ability to degranulate and synthesize mediators, mast cells are known to accumulate in tissues in both acute and chronic inflammation. Since the increase in mast cell numbers takes place within a matter of hours, it is believed that redistribution due to directed migration of mast cells within tissues is an important mechanism. Mast cell migration can be induced by a variety of ligands, including chemokines, stem cell factor and antigen.
Mast cells cross tissue boundaries, and this motility is driven by remodelling of the cytoskeleton and cell contacts with the extracellular matrix (integrin-driven). In our studies on mast cell signalling during membrane ruffling, a prelude to migration, we have reported that ongoing activation of PLD (phospholipase D) was essential [6] . Moreover, we had proposed that local availability of PA (phosphatidic acid) and ARF6 (ADPribosylation factor 6) were both required for regulating the synthesis of PtdIns(4,5)P 2 during membrane ruffling. Other studies have reached similar conclusions whereby PLD activity was required for PtdIns(4,5)P 2 synthesis for modulating the actin cytoskeleton in Dictyostelium [7] . Screening for genes involved in cell migration identified PLDB in Dictyostelium and migration speed was reduced in pldb-null cells [8] . The physical state of the actin [G-actin (globular actin) compared with F-actin (filamentous actin)] also determines PLD activity. Both β-actin and α-actinin have been shown to associate with PLD 2 and have been found to inhibit its activity in vitro [9, 10] . Likewise, PLD1 is also able to bind both G-actin and F-actin, with G-actin inhibiting activity [11] . In order to understand the complex interplay between the cytoskeletal changes induced upon antigen stimulation of mast cells and the requirement for PLD activity, we have assessed the impact of latrunculin B and cytochalasin D, two actin-modifying drugs on several mast cell functions and on antigen-stimulated PLD activity. Cytochalasin D is a cell-permeant fungal toxin which binds to the barbed end of actin filaments, inhibiting both the association and dissociation of subunits, leading to stabilization of the actin filaments. Under normal circumstances, activation of mast cells with antigen leads to increased actin polymerization and this is inhibited by cytochalasin D pretreatment [12] . Latrunculin B is another compound from Red Sea sponges that also disrupts the actin cytoskeleton. It binds to G-actin, thus preventing actin polymerization. It too prevents antigen-stimulated actin polymerization and is thus accompanied by increased degranulation [12] .
In the present paper, we report that, although both cytochalasin D and latrunculin B treatment of RBL-2H3 mast cells lead to a robust increase in antigen-stimulated PLD activation, treatment with cytochalasin D, but not latrunculin B, results in the formation Abbreviations used: ARF6, ADP-ribosylation factor 6; ATK, arachidonyl trifluoromethyl ketone; DAPI, 4 ,6-diamidino-2-phenylindole; DMEM, Dulbecco's modified Eagle's medium; DNP, dinitrophenol; ERM, ezrin/radixin/moesin; F-actin, filamentous actin; FBS, fetal bovine serum; FIPI, 5-fluoro-2-indolyl deschlorohalopemide; G-actin, globular actin; GFP, green fluorescent protein; HSA, human serum albumin; MAPK, mitogen-activated protein kinase; MLCK, myosin light-chain kinase; PA, phosphatidic acid; PIP5K, phosphatidylinositol 4-phosphate 5-kinase; PKC, protein kinase C; PLC, phospholipase C; PLD, phospholipase D; ROCK, Rho-associated kinase; TRITC, tetramethylrhodamine β-isothiocyanate. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email s.cockcroft@ucl.ac.uk).
of membrane blebs. Blebs are spherical membrane protrusions that are formed when regions of the plasma membrane separate from the underlying cell cortex, which comprises a layer of actin, myosin and associated proteins [13] [14] [15] . Normally, myosin motor proteins maintain the cortex under tension, but when the cortex is separated from the plasma membrane, cytoplasmic pressure leads to extrusion of the membrane that grow into spherical protrusions. Although blebbing occurs during apoptosis, blebs are also observed in healthy cells, i.e. during cytokinesis, cell spreading and in some cases of cell migration in threedimensional cultures and also in vivo [14, 16] . Blebbing-based motility has been observed in Dictyostelium [17] , primordial germ cells from fish and amphibians and amoebae [14] . Studies in mammalian cells are scant and are restricted to tumour cells. Blebs provide an alternative route to cell migration [16, 18] , and, as such, it is important to understand their dynamics and the molecular machinery that is required for the formation and retraction of a bleb. The main model system available for studying bleb formation in mammalian cells has been the human melanoma cell lines, particularly the M2 cells, which lacks the actin-binding protein, ABP-280 (also known as filamin-A) [19, 20] . Blebbing is observed spontaneously in these cells when allowed to reattach, i.e. during spreading. The cells initially show blebs and, after 48-72 h, the cells cease blebbing and develop membrane ruffles [19] . Loss of PIP5K1γ (where PIP5K is phosphatidylinositol 4-phosphate 5-kinase), but not other PIP5K isoforms, in megakaryotes show a blebbing phenotype similar to that seen with M2 cells [21] . An identical phenotype was also observed in megakaryotes lacking the PIP5K1γ -binding partner, talin1 [21] . Reversible blebbing stimulated by an agonist has not been reported. Migratory cells such as lymphocytes and neutrophils can switch to amoeboid migration when adhesion to the substrate is reduced as observed in neutrophils from patients where β2 integrins are reduced [22] or in the Walker carcinosarcoma cells where subcell lines were identified that used an amoeboid migratory phenotype when the cells did not adhere [23] . Amoeboid movement is characterized by a rounded blebbing morphology, independence from extracellular proteases and a requirement for high levels of actomyosin contractility downstream of RhoA-ROCK (Rhoassociated kinase) signalling [16, 18, [24] [25] [26] . In the present study, we analysed the signal transduction pathways involved in bleb formation in antigen-stimulated RBL-2H3 mast cells and report that PLC (phospholipase C) activation, and subsequently Ca 2+ -calmodulin are essential for bleb formation. Although butanol was found to inhibit membrane blebbing, a recently synthesized small-molecule inhibitor of PLD, FIPI (5-fluoro-2-indolyl deschlorohalopemide) [27] , was without effect, suggesting that PLD activation is not required.
EXPERIMENTAL

Reagents
The chemicals used were obtained from the following sources: BSA, DNP (dinitrophenol)-HSA (human serum albumin), anti-DNP IgE, calpain inhibitor I, quercetin, cytochalasin D and latrunculin B from Sigma-Aldrich; [ 3 H]inositol was purchased from GE Healthcare, U73122, U73343, wortmannin, nocodazole, LY294002, PD98056 and calmidazolium chloride were purchased from Calbiochem. SB-203580 [p38-MAPK (mitogenactivated protein kinase) inhibitor] and ATK (arachidonyl trifluoromethyl ketone) was obtained from Cayman Chemical, bisindolylmaleimide (GF 109203X) was obtained from Cell Signaling Technology, and Y27632 and blebbistatin were purchased from Tocris. A rabbit polyclonal antibody (Ab 343) that stains tubulin was made by Eurogentec.
Cell culture
RBL-2H3 mast cells were cultured at 37
• C in a humidified atmosphere of 5 % CO 2 in DMEM (Dulbecco's modified Eagle's medium) supplemented with 12.5 % FBS (fetal bovine serum), 100 units/ml penicillin, 100 μg/ml streptomycin and 4 mM glutamine. At 1 or 2 days before the experiments, the cells were harvested using trypsin and then cultured in culture plates with or without glass coverslips (thickness 0) in the presence of 5 ng/ml anti-DNP IgE.
Blebbing assay
RBL-2H3 cells primed with anti-DNP IgE were cultured on glass coverslips (thickness 0) and treated with 1 μM cytochalasin D in the presence or absence of inhibitors for 15 min at 37
• C and then stimulated with 5 ng/ml DNP-HSA for 20 min. After incubation at 37
• C, the cells were washed twice with ice-cold PBS, and then fixed with 4 % (w/v) paraformaldehyde. For measuring bleb retraction, the reaction medium containing cytochalasin D was removed 15 min after stimulation and replaced with medium containing 50 nM latrunculin B. The cells were then washed with PBS and fixed at the indicated times.
Transfection with GFP (green fluorescent protein)-tagged proteins
To transfect cells with GFP-ezrin or ARF6-GFP, RBL-2H3 mast cells were resuspended in 100 μl of Amaxa Solution R to which was added 5 μg of plasmid DNA. The cells were then electroporated in an Amaxa nucleofector (program T-20), resuspended in 2 ml of growth medium [DMEM supplemented with 12.5 % FBS, 100 units/ml penicillin, 100 μg/ml streptomycin and 4 mM glutamine] and plated in six-well plates containing glass coverslips. The cells were then incubated for 24 h in the presence of 5 ng/ml anti-DNP IgE.
Measurement of PLC activity
For measurement of inositol phosphates, the cells were labelled for 2 days with [ 3 H]inositol (2 μCi/ml) in six-well plates in the presence of 5 ng/ml anti-DNP IgE. On the day of the experiment, the cells were washed with Hepes buffer (20 mM Hepes, 137 mM NaCl, 3 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 1 mg/ml glucose and 1 mg/ml fatty-acid-free BSA, pH 7.2) containing 10 mM LiCl (to inhibit the breakdown of inositol phosphates back to inositol). The cells were treated with inhibitors for 15 min at 37
• C, and then stimulated with DNP-HSA for 15 min at 37
• C in the presence of 10 mM LiCl. At the end of the incubation, the medium was replaced with 500 μl of ice-cold methanol. The cells were then vigorously scraped and transferred to clean tubes. The tissue culture wells were rinsed with a further 500 μl of methanol, and the cellular extracts were combined in a single tube. Chloroform (1 ml) was added to the methanol cell extracts followed by 1 ml of water. Following centrifugation at 300 g for 5 min, [ 3 H]inositol phosphates were recovered in the top hydrophilic phase and were analysed on Dowex columns as described in [28] . • C and then stimulated with 5 ng/ml DNP-HSA for 15 min. At the end of the incubation, ice-cold buffer was added and then cells were centrifuged at 1000 g for 5 min. An aliquot of the supernatant (50 μl) was analysed for β-hexosaminidase as described previously [29] .
Measurement of Akt/PKB (protein kinase B) phosphorylation
RBL-2H3 cells seeded in six-well plates at 2 × 10 5 cells/well in the presence of 5 ng/ml anti-DNP IgE the day before experiment were pre-incubated for 10 min with or without cytochalasin D or latrunculin B and then stimulated with 5 ng/ml antigen for 10 min. The cells were then washed twice in ice-cold PBS and lysed with ice-cold lysis buffer [20 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1.0 % Nonidet P40 and 1 mM EDTA supplemented with mammalian cell and tissue extract protease inhibitor cocktail (Sigma) (1:100 dilution) and phosphatase inhibitor cocktails 1 and 2 (1:100) (Sigma)]. The lysed cells were scraped and diluted in reducing sample buffer. Samples of 50 μg of cell lysates were run on 12 % acrylamide SDS/PAGE gels and treated for Western blot analysis. Total and phosphorylated Akt levels were monitored by immunostaining with anti-Akt and anti-phospho-Akt antibodies (Cell Signaling Technology).
Immunofluorescence microscopy RBL-2H3 mast cells cultured on glass coverslips (thickness 0) in 24-well-plates were pre-treated with inhibitors and then stimulated with DNP-HSA. After incubation, cells were washed with PBS twice and fixed with 4 % (w/v) paraformaldehyde for 10 min at room temperature (20) (21) (22) • C). Following two washes with PBS, the cells were permeabilized in 0.2 % Triton X-100 and 0.2 M glycine in PBS for 10 min at room temperature. The cells were then blocked in PBS containing 0.5 % BSA fraction V and 0.2 M glycine (blocking solution) for 30 min at room temperature and incubated with primary antibody diluted in the blocking solution for 1 h at room temperature. The cells were then washed four times with blocking solution and incubated with Alexa Fluor ® -labelled secondary antibody (Invitrogen) for 30 min at room temperature. After four washes with PBS, the coverslips were mounted on to a 10 μl drop of Mowiol and were left to set overnight at 4
• C. For actin cytoskeleton and nuclear staining, the cells were treated with blocking solution containing TRITC (tetramethylrhodamine β-isothiocyanate)-phalloidin and DAPI (4 ,6-diamidino-2-phenylindole) for 20 min. Three-colour images were captured with an Olympus IX81 inverted microscope fitted with X-Cite 120 light (Exfo), FITC, TRITC and DAPI HQ filter sets (Chroma) and a − 20
• C cooled Orca-ER camera (Hamamatsu). The microscope and camera were controlled with the image acquisition software Cell F 2.4 (Olympus).
RESULTS
Induction of blebbing in antigen-stimulated RBL-2H3 cells pre-treated with cytochalasin D
Quiescent mast cells are elongated when plated on plastic or glass and show a smooth actin cortex. Upon addition of antigen, membrane ruffles are observed within minutes in IgE-sensitized RBL-2H3 mast cells and this is accompanied by release of secretory granules. We have reported previously that, during antigen-stimulated membrane ruffling, continual production of PA by PLD occurs. In addition, butan-1-ol, but not butan-2-ol, inhibited membrane ruffling in a reversible manner, leading to the conclusion that PLD-derived PA was required for ongoing membrane ruffling. To examine whether the polymerization state of the actin cytoskeleton influenced PLD signalling, we examined the effect of two actin-disrupting drugs in antigen-activated RBL-2H3 mast cells on PLD activation and actin dynamics. IgEsensitized RBL-2H3 mast cells were pre-treated with cytochalasin D and latrunculin B for 15 min before stimulation with antigen. Both drugs dramatically enhanced antigen-stimulated PLD activation, with cytochalasin D being more potent ( Figure 1A ). Degranulation as monitored by β-hexosaminidase release was also enhanced 2-fold compared with control cells ( Figure 1B ). The addition of the drugs on their own did not have any significant effects on basal PLD activity or degranulation. This is in accordance with a previous report that showed that both drugs increased degranulation in RBL-2H3 mast cells [12] . We also examined the effect of cytochalasin D and latrunculin B on PLC and Akt phosphorylation. Although both drugs enhanced PLC activation, Akt phosphorylation was not significantly affected ( Figures 1C and D) . In parallel studies, we observed that cytochalasin D or latrunculin B pre-treatment did not affect the typical elongated morphology of the cells before antigen activation ( Figure 1E ). However, upon stimulation with antigen, ruffle formation was inhibited in both cytochalasin D-as well as in latrunculin B-treated cells, as was evident by staining with phalloidin for F-actin ( Figure 1E ).
We also examined the cells for membrane ruffles by light microscopy and this revealed that, although membrane ruffling was inhibited in cytochalasin D-treated cells, the cells had numerous blebs after antigen stimulation ( Figure 2A and see Supplementary Movie S1 at http://www.BiochemJ.org/bj/425/ bj4250179add.htm). In contrast, latrunculin B-treated cells did not show any blebs. (Latrunculin B was tested between 50 nM and 2 μM, but was unable to induce membrane blebbing following antigen stimulation.) Once formed, the blebs were quite mobile, but did not retract (see Supplementary Movie S1). Most blebs were spherical with a straight base. The blebs were characterized with respect to the number of blebs per cell, the percentage of blebbing cells and the mean diameter of the blebs ( Table 1) . The blebs could be easily detached by vigorous shaking (results not shown).
To investigate the dynamics of bleb retraction, the cells were washed to remove cytochalasin D; the blebs started to retract spontaneously ( Figure 2B and see Supplementary Movie S2 at http://www.BiochemJ.org/bj/425/bj4250179add.htm). Retraction Table 1 ). The cells were counted from ten random images in each of three independent experiments (objective several rounds of blebbing could be achieved by successive cycles of cytochalasin D addition and removal (results not shown), demonstrating that induced bleb formation in RBL-2H3 mast cells is a reversible process and not the result of the cells undergoing apoptosis. We also examined bleb initiation in non-adherent RBL-2H3 cells. RBL-2H3 mast cells were grown in cell suspension by coating the culture dishes with 2 % agarose to prevent cell adhesion [30] . In cytochalasin D-treated cells, blebs were readily observed upon antigen stimulation suggesting that bleb formation is anchorage-independent ( Figure 2C ).
State of the actin cortex during bleb dynamics
Blebs are defined as membrane protrusions which can be distinguished from other cellular protrusions such as lamellipodia or filopodia by the absence of polymerized actin filaments; cytosolic proteins are present in the blebs [13, 15, 31] . Antigenstimulated blebs were examined by wide-field fluorescence microscopy after fixation and staining with TRITC-phalloidin to visualize actin filaments and with an antibody against tubulin. The blebs stained with tubulin, but no actin filaments were observed in the blebs ( Figure 3A ). Confocal analysis of the cells revealed that the blebs were devoid of actin filaments and that the actin cortex surrounding the cell body remained unaffected at the base of the bleb ( Figure 3B ). Additionally, tubulin was present in the blebs, although microtubules were not observed. Following cytochalasin D washout, actin filaments were observed to accumulate at the cortex of the retracting blebs ( Figure 3C ).
Expression of ezrin-T567D inhibits bleb formation
For the membranes to bleb, local detachment of the membrane from the actin cortex has to occur [13, 14] . The actin cortex makes many interactions with the overlying membrane, and either loss of adhesive strength or gaps in the cytoskeleton (or both) enable the pressure to form blebs. To examine whether proteins that increase the attachment of the plasma membrane with the actin cytoskeleton will counteract bleb formation, we expressed an active form of ezrin. Ezrin belongs to the ERM (ezrin/radixin/moesin) family of proteins that can bind both the plasma membrane via their N-terminal ∼ 300-residue FERM (4.1/ezrin/radixin/moesin) domain and the actin cytoskeleton via their C-terminal domain [32, 33] . ERM proteins can exist in dormant or active conformations; in the dormant state, the F-actinbinding site is masked. The activation of ERM proteins is mediated by both C-terminal threonine phosphorylation and exposure to PtdIns(4,5)P 2 [34] . Active ERM proteins could therefore maintain membrane attachment to the actin cortex and prevent blebbing. Overexpression of the phosphomimetic constitutively active ezrin mutant (T567D) has been found to inhibit blebbing [20] . We therefore expressed GFP-tagged wildtype ezrin and ezrin-T567D in RBL-2H3 mast cells. Following transfection, many cells expressed the ezrin mutant, whereas the number of cells expressing the wild-type protein was always low. Wild-type ezrin localized mostly to the nucleus and the cytoplasm of resting cytochalasin D-treated cells, and, upon antigen stimulation, moved to the plasma membrane (results not shown). In contrast, ezrin-T567D was concentrated at the plasma membrane before antigen stimulation ( Figure 4A ). Cells expressing the wild-type protein still form blebs; wildtype ezrin was not observed at the rim of the blebs, although it was present in the bleb cytosol. Nonetheless, it was enriched at the plasma membrane at the base of the blebs (results not shown). In cells expressing ezrin-T567D, no blebs were observed following antigen stimulation ( Figure 4A ). Quantification showed that less than 10 % of cells expressing ezrin-T567D produced blebs compared with 90 % of control cells ( Figure 4B ). Taken together, these results demonstrate that ezrin resides in the cytosol of resting RBL-2H3 mast cells and, upon cross-linking of the IgE receptor, it can translocate to the plasma membrane. Nonetheless, it does not prevent bleb formation. This may be explained by the rapid intrinsic turnover of Thr 567 phosphorylation [35] . In contrast, overexpression of constitutively active ezrin is sufficient to prevent antigen-stimulated bleb formation.
The activity of myosin II is required for bleb formation, but not membrane ruffling
Bleb nucleation is initiated by the rapid detachment of a local patch of membrane from the cortex, and this requires intracellular pressure transients that are generated by myosin II contraction of the actin cortex; drugs that relax the cortex can inhibit blebbing [20] . In antigen-stimulated cells, inhibition of the ATPase activity of the myosin II motor protein with blebbistatin completely inhibited plasma membrane blebbing. In contrast, membrane ruffling was unaffected by blebbistatin (Figures 5A and 5B and Table 2 ).
PLC-dependent pathways are required for antigen-stimulated blebbing in RBL-2H3 cells
To examine which of the signalling pathways were required for bleb formation in RBL-2H3 mast cells, we used a number of inhibitors that have been described previously to interrupt specific signalling pathways ( Figure 5A ). The requirement for PLC activity for bleb formation was tested using the inhibitor U73122; it completely blocked bleb formation. As a control, the inactive homologue U73343 was used and it had no effect on blebbing. Wortmannin, a covalent inhibitor of PI3K (phosphoinositide 3-kinase), also inhibited blebbing, and, similarly, bleb formation was significantly reduced in cells treated with LY294002 (results not shown). The above inhibitors not only inhibited blebbing, but also inhibited membrane ruffling indicating that the upstream signalling events were identical for both ( Figure 5B and Table 2 ).
Since PLC activation was needed, additional inhibitors were used to test the requirement for a rise in cytosolic Ca 2+ and for activation of PKC (protein kinase C) by DAG (diacylglycerol). Treatment with the chelating agent EGTA, which prevents Ca 2+ entry, completely repressed blebbing, suggesting that Ca 2+ influx via plasma membrane Ca 2+ release activated channels is a requirement for bleb formation. Ca 2+ can bind to calmodulin and an inhibitor of calmodulin, calmidazolium chloride, was therefore tested; it was found to also inhibit bleb formation ( Figure 5A ). Likewise, inhibition of PKC by treatment with BIM (bisindolylmaleimide) blocked membrane blebbing completely ( Figure 5A ). However, phospholipase A 2 activation was not required, as ATK had no effect on blebbing, and blocking MAPKs p38 and ERK (extracellular-signal-regulated kinase), which are late effectors downstream of PKC, had also no effect ( Figure 5A ).
Two separate pathways can regulate myosin II activity: a Rho/ROCK pathway, which is Ca 2+ -independent and functions by phosphorylating myosin phosphatase to inhibit its activity, and a Ca 2+ -dependent pathway, which involves a Ca 2+ -calmodulin complex that can activate MLCK (myosin light-chain kinase) to phosphorylate the myosin light chain of myosin II. To examine the contribution of the Rho/ROCK pathway, we used the ROCK inhibitor Y27632. This inhibitor only partially blocked membrane blebbing ( Figure 5A ). In Table 1 , we compare the degree of inhibition by the calmodulin inhibitor and the ROCK inhibitor. We indicating that myosin II contractility is specifically required for blebbing ( Figure 5B and Table 2 ). Finally, we checked whether calpain may be required for blebbing as it has been implicated in the control of cytoskeletal dynamics. However, calpain inhibitor I was unable to prevent antigen-stimulated membrane blebbing or membrane ruffling ( Figure 5 ).
Inhibitors of PA production via PLD activity block membrane blebbing
PLD-derived PA has been found to be an important signalling molecule that regulates the dynamic changes in the actin cytoskeleton that is obligatory for cell adhesion, spreading and migration [36] . We used butan-1-ol, a preferential substrate for PLD activity that inhibits PLD-mediated PA production, and looked at its effect on bleb formation. As shown in Figure 6 (A) and Table 2 , bleb formation was inhibited in cells treated with butan-1-ol, but not butan-2-ol, which is not a substrate for PLD. In our search for alternative inhibitors of PLD activity, we identified quercetin ( Figure 6B ). At concentrations that inhibit PLD activation without effect on PLC activation ( Figure 6C ) or membrane ruffling ( Figure 5B ) (10 μM), quercetin was found to inhibit membrane blebbing ( Figure 5A ). These data collectively suggest that PLD activation and therefore PA may be an important component required for bleb formation.
Use of a new PLD inhibitor, FIPI, reveals that PLD activity is not required for many mast cell functions
To date, primary alcohols have been widely used to implicate the requirement for PLD activity for specific biological functions.
Despite their limitations because of additional effects unrelated to PLD signalling, they have remained popular tools. FIPI has been identified as an inhibitor of PLD activity [27, 37] . It inhibits both PLD1 and D2 activity both in vitro and in vivo, making it possible to reassess the requirement of PLD using more selective inhibitors.
We first characterized FIPI as an inhibitor of PLD activation in antigen-stimulated RBL-2H3 mast cells. FIPI inhibited antigenstimulated PLD activity in a concentration-dependent manner with maximum inhibition achieved at 75 nM ( Figure 7A ). At this concentration, 75 nM FIPI was found to inhibit both PMAand cytochalasin D plus antigen-stimulated PLD activation ( Figure 7B ). FIPI was introduced as a PLD inhibitor on the basis of in vitro analysis, and its effects on PLC activation when applied to intact cells have not been investigated. When tested at concentrations that maximally inhibited PLD activation, PLC signalling was not affected in RBL-2H3 mast cells stimulated with antigen ( Figure 7C ). On the basis of this analysis, we were satisfied that FIPI is a potent inhibitor of antigen-stimulated PLD activity and that it is relatively specific, as no significant inhibition of PLC was observed.
FIPI-treated cells were examined for membrane blebbing (in the presence of cytochalasin D), membrane ruffling and degranulation which are all responses that can be inhibited by primary alcohols, but not secondary alcohols. To our surprise, 75 nM FIPI did not prevent bleb formation ( Figure 7E ), membrane ruffling ( Figure 7F ) or degranulation ( Figure 7D ) in antigen-stimulated cells. In other experiments, we also used FIPI at 750 nM, and even at this concentration, FIPI was without effect (e.g. Figure 7D ). Taken together, these results demonstrate that FIPI is a specific inhibitor of PLD activation in RBL-2H3 mast cells, but that inhibition of PLD does not block membrane ruffling, blebbing or exocytosis. Table 2 . The cells were fixed and the cytochalasin D-treated cells were examined for blebbing by DIC (differential interference contrast) microscopy (A), and, to examine membrane ruffling, the fixed cells were stained with TRITC-phalloidin (B). BIM, bisindolylmaleimide; Calm, calmidazolium chloride; Calpain inhib I, calpain inhibitor I; SB, SB203580.
ARF6 potentiates blebbing via PLD signalling
To explore further the connection between PLD and membrane blebbing, we examined ARF6, a regulator of both PLD and of PIP5K activity that is also required for membrane ruffle formation in HeLa cells [38] . We expressed four GFP-tagged ARF6 constructs, including wild-type ARF6, inactive ARF6-T27N, constitutively active ARF6-Q67L and a double mutant, N48R/Q67L, which is constitutively active, but defective in PLD, but not PIP5K, activation [39] [40] [41] . Wild-type ARF6 was present at the rim of the blebs after antigen stimulation. Strikingly, the blebs were of a significantly larger size in cells expressing wild-type ARF6, compared with the neighbouring non-expressing cells ( Figure 8A ). In contrast, inactive ARF6-T27N was enriched in the cytoplasm and did not localize to the bleb cortex upon antigen stimulation. Furthermore, cells expressing this construct were much thinner and more elongated than control cells and made blebs of normal sizes when stimulated ( Figure 8B ). The constitutively active ARF6-Q67L localized to the plasma membrane and the cells had a wider body and shorter extensions than untransfected neighbouring cells ( Figure 8C ). More importantly, antigen stimulation resulted in the formation of giant blebs and ARF6-Q67L was enriched in the rim of the blebs.
Although PLD activity was not necessary for bleb formation, it was still possible that it could play a more subtle role in regulating the size of the bleb. To examine this possibility, we used the ARF6 double mutant (N48R/Q67L) which is unable to activate PLD. This mutant localized to the plasma membrane in resting cells and to the rim of the blebs upon stimulation. However, in cells expressing ARF6-N48R/Q67L, antigen stimulation resulted in the formation of blebs of a normal size, compared with control cells, suggesting that PLD activity could contribute to bleb size. In Figure 8 (E), the bleb diameter was monitored. To quantify the changes, we measured the bleb diameter of the transfected cells and compared them with their untransfected neighbours Figure 8E ). The mean bleb diameter of all the non-transfected cells is ∼ 3.3 μm and is seen to increase to 5.4 μm, when wild-type ARF6 is expressed and to 6.5 μm, when the constitutively active form of ARF6-Q67L is expressed ( Figure 8E ). The bleb diameter is considerably smaller when the ARF6 mutant that is unable to stimulate PLD activity was examined, even when compared with wild-type ARF6. These data support the suggestion that PLD activation may influence the bleb diameter.
DISCUSSION
In the present paper, we report that perturbation of the actin cytoskeleton by cytochalasin D treatment leads to a switch from ruffling to membrane blebbing in RBL-2H3 mast cells stimulated with antigen. Once formed, the blebs remain stationary and are devoid of F-actin. Following washout of cytochalasin D, the blebs retract in a process dependent on actin polymerization; an actin cortex could be observed in the retracting blebs, and addition of latrunculin B during bleb retraction was found to be inhibitory ( Figure 3C ). For blebbing to occur, the local interaction between the cytoskeleton and the plasma membrane must be impaired. Nonetheless, actin is observed at the base of the bleb ( Figure 3B ), suggesting that the interactions between the actin cortex and the membrane have been disrupted. To test whether proteins that would strengthen the interaction between the plasma membrane and the actin cytoskeleton, we used an ezrin mutant, ezrin-T567D. This phosphomimetic form of ezrin is maintained in its open configuration and can therefore interact with both the plasma membrane and the actin cytoskeleton in a constitutive manner. The ezrin mutant, when expressed in RBL-2H3 mast cells, localizes to the plasma membrane and inhibits bleb formation, supporting the notion that maintaining the tight association between the plasma membrane and the actin cytoskeleton is inhibitory for bleb formation.
Since blebbing requires activation of the cells with antigen, we examined the signalling pathways that are required. We also monitored membrane ruffling in parallel to examine whether the signalling pathways leading to both these functional responses could by separated. Using a variety of inhibitors, we show that blebbing requires the activation of PLC as well as the activity of PKC and a rise in cytosolic Ca 2+ . Since both chelation of extracellular Ca 2+ with EGTA and the calmodulin inhibitor calmidazolium inhibited bleb formation, but not membrane ruffling, this suggested that Ca 2+ -calmodulin regulates a downstream event that is essential for bleb formation.
Bleb expansion is likely to be driven by hydrostatic pressure produced by cortical contraction involving myosin II, and this conclusion is supported by the studies with blebbistatin. Blebbistatin inhibits the activity of myosin II ATPase and was found to inhibit bleb formation. The activity of myosin II can be regulated by either Ca 2+ -calmodulin-dependent phosphorylation of MLCK or by ROCK. Since both EGTA and the calmodulin inhibitor blocked membrane blebbing, we conclude that Ca 2+ -calmodulin is the main route to regulate myosin II-dependent contractility. To examine whether ROCK made a contribution, we used Y27632. With this compound, a partial inhibition was observed. Both the calmodulin inhibitor and the ROCK inhibitor led to a decrease in the number of blebbing cells as well as in the number of blebs made per cell. Compared with the calmodulin inhibitor, the inhibition observed with the ROCK inhibitor was modest. In most types of blebs reported to date, bleb dynamics have involved signalling through the Rho/ROCK/myosin cascade in which the small GTPase Rho recruits and activates ROCK to phosphorylate myosin light chain, thereby inducing myosin contraction and increase of local pressure [18, 42, 43] . In RBL-2H3 mast cells, it would appear that this pathway is less relevant, and that Ca 2+ -calmodulin regulation of myosin II plays a more dominant role. We cannot exclude the possibility that the kinase MRCK (myotonic dystrophy-related Cdc42-binding kinase), which is regulated by Cdc42, could contribute to myosin light chain phosphorylation and hence regulate myosin II contractility in mast cells [24] .
Requirement for PLD in membrane blebbing
Since our early studies on membrane ruffling and degranulation had indicated clearly that activation of PLD was required, we explored the possibility that PLD activation was also essential for membrane blebbing. To examine this, we used a primary alcohol, butan-1-ol, and a secondary alcohol, butan-2-ol, as a control. Butan-1-ol participates in transphosphatidylation, leading to a decrease in PA production by PLD at the expense of the product, phosphatidylbutanol. PA is able to regulate the activity of PIP5K and hence increase the amount of PtdIns(4,5)P 2 locally [44] . Since PtdIns(4,5)P 2 is important in the regulation of the dynamics of the actin cytoskeleton, PLD could be an important regulator. In cytochalasin D-treated cells, the stimulation of PLD activity by antigen was also enhanced. When antigen-stimulated cells were examined for bleb formation in the presence of butan-1-ol, blebbing was completely inhibited, but no inhibition was observed in the presence of the secondary alcohol.
To evaluate further the importance of PLD activity, we screened for inhibitors of PLD activity and identified that, at low concentrations, quercetin was a potent inhibitor of antigen-stimulated PLD in mast cells. Quercetin did not inhibit PLC activation and neither did it inhibit membrane ruffling. This strengthened further the suggestion that PLD activation was essential for membrane blebbing, but also raised other issues. Since membrane ruffling was not affected by quercetin, despite complete inhibition of PLD activity, this implied that our previous studies which had relied on the use of alcohols [6] may need to be re-evaluated.
While this work was in progress, it was reported that FIPI was identified as a potent inhibitor of both PLD 1 and PLD 2 both in vitro and in vivo [27] . PLD has been linked to regulated exocytosis in many cell types, including neutrophils, mast cells and pancreatic β-cells, based on the observation that the agoniststimulated exocytosis is inhibited by primary alcohols [45] . FIPI was tested for glucose-induced insulin secretion, and, although FIPI inhibited PLD activation, no inhibition of glucosestimulated insulin release was observed. From their study they concluded that PLD activity was not required for insulin release and that inhibition by butan-1-ol must occur through another mechanism.
We tested FIPI in RBL-2H3 mast cells and established that FIPI was a potent inhibitor of antigen-stimulated PLD activity. A concentration of 75 nM was sufficient for maximal inhibition. At this concentration, it also inhibited the enhanced activity observed in the presence of cytochalasin D as well as PMAinduced PLD activation. FIPI was without effect on PLC activation. To our surprise, we have found that FIPI did not inhibit antigen-stimulated degranulation, membrane ruffling or membrane blebbing. From these data, we conclude that previous studies which had relied on primary alcohols to demonstrate a role for PLD need to be re-evaluated. It is of interest that primary alcohols do inhibit exocytosis in many cell types and it would be of real interest to identify the targets of primary alcohols.
One of the reasons that PLD-derived PA was such an attractive candidate for modulating the actin cytoskeleton was the potential of PA to regulate PIP5K activity. It is now clear that PIP5K activity can be regulated independently of PA by the GTPase ARF6. Honda et al. [38] purified ARF6 as a co-factor acting with PA to stimulate PIP5K activity, and ARF6 was identified as a requirement for membrane ruffle formation. Subsequent work identified that PIP5K could be regulated directly by ARF proteins [46] . The ability of ARF proteins to regulate PIP5K activity is evolutionarily conserved: Plasmodium PIP5K can be regulated by ARF proteins, but not by PA [44, 47] . It was therefore of interest to examine the importance of ARF6 in membrane blebbing. Expression of wild-type ARF6 was found to affect the diameter of the bleb, and this was even more dramatic in cells where the constitutively active ARF6-Q71L was used. To examine whether PLD activation in the bleb may have some subtle role, we used an ARF6 mutant that is unable to activate PLD, whereas it remains competent to activate PIP5K. The bleb diameter was significantly reduced when this mutant ARF6 was expressed. We therefore conclude that, although activation of PLD is not essential for bleb formation, it has an influence on the bleb diameter. We cannot exclude the possibility that ARF6 has other as yet identified downstream effectors that this mutant is unable to activate. We would cautiously suggest that PA can influence the size of the membrane blebs. This would be very important, particularly for cells that move by blebbing such as metastatic cells that can switch to the blebbing mode for migration when transferred to three-dimensional matrices [18] . Thus a recent study that has described chemically synthesized PLD inhibitors also based on halopemides reported that PLD activity plays an essential role in invasiveness in highly metastatic breast cancer cell lines [48] . Epifluorescence images and DIC (differential interference contrast) images show that, compared with non-expressing neighbouring cells, the blebs are more prominent in cells expressing ARF6-WT and ARF6-Q67L than in ARF6-T27N or the double mutant N48R/Q67L. (E) These images are representative and the data were quantified by measuring the bleb diameter from the transfected population (T) and compared with its neighbouring non-transfected cells (U). The total number of cells counted in each condition is indicated beneath the box plot, which is a summary plot representing statistical values. The boundary of the box closest to zero indicates the 25th percentile, a line within the box marks the median, and the boundary of the box furthest from zero indicates the 75th percentile. Whiskers (error bars) above and below the box indicate the 90th and 10th percentiles. The outlying points are also included, represented by black circles. The transfected population with wild-type ARF6 and ARF6-Q67L shows a high variance, probably reflecting different levels of expression in the population.
Tumour cell invasion through the extracellular matrix is accompanied by the formation of invadopodia, which are actinrich protrusions at the adherent surface of cells at sites of extracellular degradation, and ARF6 has been shown to be important in this process [49, 50] . Interestingly, the effects of ARF6 are upstream of PLD activation. If bleb size determines migration speed then the increased invasiveness of cells expressing ARF6 using invadopodia might suggest that, during blebbing-driven motility, the degree of ARF6 activation might determine the speed of movement.
